Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Crinetics Pharmaceuticals in June, 2018 for $1,895,558.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK115290-02 | Phase II | 1,895,558 | June 6, 2018 | |||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals in September, 2017 for $299,510.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK115245-01 | Phase I | 299,510 | September 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Crinetics Pharmaceuticals in February, 2015 for $1,499,966.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HD070568-02 | Phase II | 1,499,966 | February 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals in April, 2015 for $326,121.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44NS092231-01 | Phase I | 326,121 | April 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Crinetics Pharmaceuticals in April, 2017 for $2,802,411.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK088501-04A1 | Phase II | 2,802,411 | April 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals in August, 2017 for $297,358.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK115290-01 | Phase I | 297,358 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals for $282,070.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK088501-01A1 | Phase I | 282,070 | ||||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals for $296,283.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD070568-01A1 | Phase I | 296,283 | ||||||||
A SBIR Phase II contract was awarded to Crinetics Pharmaceuticals for $2,162,550.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK088501-02A1 | Phase II | 2,162,550 | ||||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals for $237,895.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM088912-01A1 | Phase I | 237,895 | ||||||||
A SBIR Phase I contract was awarded to Crinetics Pharmaceuticals for $224,092.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY024185-01 | Phase I | 224,092 |